Eurocine Vaccines is a pharmaceutical company. The company develops vaccines using its proprietary technology platform Endocine™, which vaccines are subsequently licensed to partners for further development and commercialization. Development is carried out in cooperation with other companies in the industry. The technology platform Endocine™ is also offered to other companies for development within certain indications. The head office is located in Solna.

Quotes for Eurocine Vaccines AB

Right Now

+/-
-0.045
%
-3,46%
Latest
1.255
High
1.31
Low
1.255
Volume
7 397
Turnover (SEK)
9 408
Market Value (MSEK)
21,8
Time (Latest trade)

Board

CEO

  • Hans Arwidsson

Chairperson of the Board

  • Pierre Morgon

Board

  • Emanuele Montomoli
  • Hans Arwidsson
  • Jan Sandström
  • Pär Thuresson

Videos

Largest Owners

Name Capital % Votes % Date
Thomas Eldered 13,73 13,73 2022-03-31
Avanza Pension 4,65 4,65 2022-03-31
Nordnet Pensionsförsäkring 2,89 2,89 2022-03-31
Jan Kenneth Karjalainen 1,45 1,45 2022-03-31
Kent Olsson 1,07 1,07 2022-03-31
Göran Erlandsson 1,02 1,02 2022-03-31
VisMederi Srl 0,96 0,96 2021-12-31
Mats Kenneth Pettersson 0,75 0,75 2022-03-31
Robert Grebenstedt 0,73 0,73 2022-03-31
BRL Invest AB 0,72 0,72 2022-03-31
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2022-08-25 Bokslutskommuniké 2022